Protagonist Therapeutics Inc. has announced a forthcoming conference call and webcast set to occur on Monday, June 30th, at 4:30 pm ET, during which the company will unveil its new oral obesity development candidate. The event will include a presentation of in vitro and pre-clinical proof-of-concept study results related to the candidate. Interested parties can join the webcast through a provided link, and a replay of the presentation will be accessible on Protagonist's Investor Relations webpage following the event.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1043214) on June 26, 2025, and is solely responsible for the information contained therein.